Similarly, the expression of Nrf2 as well as its downstream target genes such as UGT1A1, GSTM1 and NQO1 were found to be gradually down-regulated in prostate tumors with the progression of prostate tumorigenesis in TRAMP mice [10]. This evidence concerns the gene NFE2L2 and urogenital neoplasm.